Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

Corstasis to present pivotal trial data on Bumetanide Nasal Spray at AHA 2024, highlighting safety, and efficacy. #AHA2024.

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

COLLEGE STATION, Texas — November is National Alzheimer's Awareness Month and now a new therapy out of Texas A&M University could treat Alzheimer's disease through a nasal spray. Seven million ...

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

Permatan’s encapsulation technology is still relatively new, and there are few long-term studies on its effectiveness and ...

Many people rely on nasal sprays to relieve stuffy noses, but using them too often can lead to nasal spray dependency. ALSO ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak ...

ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...